Latest Breaking News On - லிங்கன் மருந்துகள் - Page 5 : comparemela.com

Lincoln Pharmaceuticals consolidated net profit rises 23 56% in the December 2020 quarter

Lincoln Pharmaceuticals consolidated net profit rises 23 56% in the December 2020 quarter
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Particularsquarter endeddecLincoln pharmaceuticalsVar salesCapital marketலிங்கன் மருந்துகள்வார் விற்பனைமூலதனம் சந்தை

Lincoln Pharma Q3 net up 31% - The Hindu BusinessLine

Lincoln Pharma Q3 net up 31% February 02, 2021 Pharma player, Lincoln Pharmaceuticals Limited posted standalone net profit at ₹13 crore for the quarter ended December 2020 as against ₹10 crore in the corresponding quarter last year, indicating a rise of 31 per cent. The company reported ₹112 crore as standalone revenues from operations during the quarter, which was about 17 per cent higher from the ₹96 crore reported in the same period last year. Standalone EBITDA for the quarter increased by 43 per cent to ₹20 crore from ₹14 crore in the same quarter last year. For the nine-month period, standalone profit stood at ₹49 crore, up from ₹40 crore in the same period previous year with revenues from operations rising to ₹336 crore as against ₹301 crore in the corresponding period last year. Mahendra Patel, MD, Lincoln Pharmaceuticals, said, “On the back of strong domestic and international business, the company posted 15.56 per cent sales growth, 4 per cent

Mahendra patelLincoln pharmaceuticalsLincoln pharmaceuticals limitedSoutheast asianமகேந்திரா படேல்லிங்கன் மருந்துகள்லிங்கன் மருந்துகள் வரையறுக்கப்பட்டவைதென்கிழக்கு ஆசிய

Lincoln Pharma Q3 net up 23% to Rs 13 cr on strong domestic, global biz

On the back of strong domestic and international business, Lincoln Pharmaceuticals Limited posted a 23.44 per cent rise in its consolidated net profit for the third quarter ended December 31, 2020 at Rs 13.48 crore, from Rs 10.92 crore in the same quarter last year. The drug maker s consolidated total revenue also grew by 13.70 per cent to Rs 115.47 crore in Q3 of FY 2020-21, from Rs 101.55 crore in Q3 of FY 2019-20. According to Lincoln Pharma s managing director Mahendra Patel, the growth in revenue and profit came on the back of strong domestic and international business. The company posted a 15.56 per cent growth in sales and a four per cent growth in exports. Moreover, the company s exports grew by 17.56 per cent year-on-year (YoY) basis for the nine months ended December 31, 2020 at Rs 212.47 crore.

Lincoln pharmaMahendra patelLincoln pharmaceuticalsLincoln pharmaceuticals limitedSoutheast asianலிங்கன் பார்மாமகேந்திரா படேல்லிங்கன் மருந்துகள்லிங்கன் மருந்துகள் வரையறுக்கப்பட்டவைதென்கிழக்கு ஆசிய

market outlook: Ahead of Market: 12 things that will decide stock action on Friday

Nifty formed a small bearish candle with a long lower shadow on the daily chart in Thursday s session. The 50-pack index negated the formation of higher highs and lows of the last nine sessions. Defensive viz. FMCG, IT and pharma tend to do well during the corrective phase, but traders should maintain caution in the selection of the stocks as we’re seeing selective participation, said Ajit Mishra, VP - Research, Religare Broking. He also added, Indications are in the favour of some consolidation in the index and it would be healthy for the markets. Nifty has critical support at 13,350 and its breakdown may result in further correction ahead. In the case of a rebound, the 13,550-13,600 zone would act as a hurdle.

United kingdomCity ofAjit mishraCera sanitarywareMazhar mohammadCreditaccess grameenThomas cookVinod nairBirla corporationFinolex industriesTd power systems ltdLincoln pharmaceuticalsEuropean central bankTanla solutionsCanara bankTinplate company of india